News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Internal Fixation Systems Featured Cover Story in February Issue of MicroCap Review


1/27/2012 10:18:01 AM

SOUTH MIAMI, Fla., Jan. 26, 2012 /PRNewswire/ -- Internal Fixation Systems, Inc. (OTCQB: IFIX),a designer, manufacturer and marketer of high quality, value priced orthopedic and podiatric implants is pleased to report that the February issue of Micro-Cap Review Magazine will feature Internal Fixation Systems (IFS) as its feature cover story. The article will profile Internal Fixation Systems and its innovative approach to addressing the critical cost control issues of the orthopedic implant industry. The IFS issue is due out in the first week of February.

Micro-Cap Review is delivered via hard copy print to numerous individual investors and investing professionals. Each issue of the magazine is also sent electronically to several hundred thousand investors around the world. To receive a free copy from the publisher, investors can sign up at www.microcapreview.com. This new edition of Micro-Cap Review will be posted on their new website soon.

Stephen J. Dresnick, MD, IFS's President and CEO said, "We believe it's time to bring our exciting story to investors across the country. I am thrilled that Micro-Cap Review has chosen to feature IFS in their publication. We are addressing the critical issue of providing high quality implants in an environment which is extremely cost conscious. We believe our story has relevance to a wide range of investors."

About IFS: Internal Fixation Systems, Inc is a manufacturer and marketer of high quality, responsibly priced orthopedic and podiatric implants. We seek to prove that superior products and lower costs can go hand in hand. IFS focuses on widely used, market proven products used to treat common fractures. Our Advisory Panels, consisting of nationally recognized surgeons, provides input on how to improve our implant designs. The resulting products incorporate doctor requested enhancements and are priced at 40-60% less than the competition. IFS provides superior value through its innovative set designs, use of standardized components and instruments across product lines, and our multiple distribution pathways. IFS customers include ambulatory surgery centers, hospitals and orthopedic surgeons. Please contact us for more information about our product and business model.

This press release contains projections and forward-looking information that involve various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of Internal Fixation, such as whether we sell our new product offering There are numerous risks and uncertainties that could cause actual results and Internal Fixation's plans and objectives to differ materially from those expressed in the forward-looking information, including whether Internal Fixation will have sufficient capital to continue its operations. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and views of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, IFS does not intend to update these forward-looking statements.

For further information, please contact:

Laura Cattabriga, Chief Financial Officer

Tel: 786 268 0995

Laura.cattabriga@ifsusa.net

SOURCE Internal Fixation Systems, Inc.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES